Hmmm, this deduction made before the company even started their "Deep Data Dive"?
Not to be picky, but this poster was actually 2 patients "off the number". You see there were 194 total patients in the "sweet spot" or "Golden Hour" range. Bearing this in mind, Canadien sites needed to be "extracted" so all 16 Canadien sites were removed from the 194 bringing us to 178 patients. One patient was added ( not too sure from where ) to bring us up to 179 for purposes of the Baysian Stats and of course the hard data to provide about 40% of the data required for the current phase 3B FDA confirmatory trial called TIGRIS. Bear in mind once more, we are using our PMX medical device on a "2 to 1" ratio over the placebo or "SOC" ( standard of care ) in this important trial where the primary endpoint is based on the most challenging 28 day mortality. I will point out that when the 16 Canadien sites were removed/extracted from the 194 per patient protocol, the number of PMX applications DID NOT drop, only the placebo / standard of care. Data indicates that Canadien sites in the per protocol group DID NOT actually administer the PMX filter, but rather the standard of care.
ONLY the last 176 patients matter - why is 450 # shared?
This smells worse than the interim data analysis.
STOCKWATCH says NOTHING about 18% number
Girl in India claims FAILURE thru Reuters
Walker says ROBUST data to go to FDA
This NEWS release is a shameful piece of garbage
Sqr